COLORECTAL CANCER SCREENING TESTS
Several tests available for colorectal cancer screening can detect precancerous polyps (adenomas) and can lead to cancer prevention and/or detect cancers at an early, more treatable stage.
Guidelines from expert groups recommend that you and your health care provider discuss the available options and choose a testing strategy that works best for you.
Colonoscopy
Colonoscopy allows a clinician to see the lining of the entire colon, including the rectum.
Sigmoidoscopy
Sigmoidoscopy allows a clinician to directly view the lining of the rectum and the lower part of the colon. This area accounts for about one-half of the total area of the rectum and colon.
Having polyps or cancers in the lower colon increases the likelihood that there are polyps or cancer in the remaining part of the colon. Thus, if sigmoidoscopy reveals polyps or cancer, colonoscopy is recommended to view the entire length of the colon.
CT colonography
Computed tomography colonography “virtual colonoscopy” is a test that uses a CT scanner to take images of the entire colon. These images are two- and three-dimensional and are reconstructed to allow a radiologist to determine if polyps or cancers are present. The major advantages of CTC are that it does not require sedation, it is noninvasive, the entire bowel can be examined, and abnormal areas (adenomas) can be detected about as well as with traditional (optical) colonoscopy.
There are some disadvantages of CTC. Like traditional colonoscopy, CTC usually requires a “bowel prep” to clean out the colon. If an abnormal area is found with CTC, a traditional colonoscopy will be needed to see the area and take a tissue sample (biopsy)..
Stool tests
Colorectal cancers often release microscopic amounts of blood and abnormal DNA into the stool. Stool tests can detect blood or abnormal DNA markers. Although these tests involve collecting stool samples at home, they require a prescription from a doctor.
Two types of tests, fecal occult blood testing (also called guaiac testing, or gFOBT) and fecal immunochemical testing (FIT), evaluate the stool for blood, which may be present if there is bleeding from a colorectal cancer (or other source).
If a stool test is positive, your entire colon should be examined with colonoscopy.
Stool testing reduces the risk of dying from colorectal cancer. However, because polyps seldom bleed, stool testing for blood is less likely than other screening tests to detect polyps. In addition, “false positives” are common, meaning that many people with a positive stool test will not turn out to have colorectal cancer.
A FIT-DNA test is another option and is done every three years. This test looks for specific DNA markers that may signify the presence of a colorectal cancer, and it also looks for blood in the stool. For this test, you get a special kit in order to collect a whole bowel movement. Then you follow the instructions about how and where to ship it. An abnormal test result should be followed up by colonoscopy.